Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 5219-5222, October 1, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zha, X.
Right arrow Articles by Morrison, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zha, X.
Right arrow Articles by Morrison, G. H.

Quantitative Imaging of a Radiotherapeutic Drug, Na2B12H11SH, at Subcellular Resolution in Tissue Cultures Using Ion Microscopy1

Xiaohui Zha, Walter A. Ausserer2 and George H. Morrison3

Department of Chemistry, Cornell University, Ithaca, New York 14853

The effectiveness of boron neutron capture therapy is predicted to be dependent not only on the amount of boron taken up by the target cells but also on the intracellular distribution of boron. Using the isotopic imaging technique ion microscopy, we have quantitatively determined uptake and intracellular distribution of Na2B12H11SH, a promising boron drug for boron neutron capture therapy, in four human cell lines: U87 glioblastoma cells, HeLa epitheloid carcinoma cells, GM 2408b mutant skin fibroblasts, and GM 3348b skin fibroblasts. The boron uptake of all four cell lines, after exposure to 100–500 µg/ml Na2B12H11SH, increased as the dosages were increased but showed a tendency toward saturation. Boron was more concentrated in the cytoplasm than in the nucleus but was not strongly localized within cells. There were no significant differences in boron uptake among the four cell lines. A retention experiment identified at least two different intracellular boron pools, and cells lost >60% of intracellular boron within 1 h upon changing to Na2B12H11SH-free medium, indicating a largely low affinity binding.

1 Supported by United States Department of Energy Grant DE-FG02-91ER61138 and NIH Grant GM 24314 to G. H. M.; W. A. A. was partially supported by the Department of Energy-funded Power Burst Facility/Boron Neutron Capture Therapy Program for Cancer Research.

2 Current address: SRI International, 333 Ravenswood Ave., Menlo Park, CA 94025.

3 To whom requests for reprints should be addressed, at Baker Laboratory of Chemistry, Cornell University, Ithaca, NY 14853.

Received 2/17/92. Accepted 7/23/92.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
S. Chandra, G. W. Kabalka, D. R. Lorey II, D. R. Smith, and J. A. Coderre
Imaging of Fluorine and Boron from Fluorinated Boronophenylalanine in the Same Cell at Organelle Resolution by Correlative Ion Microscopy and Confocal Laser Scanning Microscopy
Clin. Cancer Res., August 1, 2002; 8(8): 2675 - 2683.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.